Using genetics to deliver personalized SLE therapy-a realistic prospect?

Area of Science:

• Immunogenetics
• Human Genetics
• Complex Genetic Diseases

Background:

• Significant progress has been made in understanding the genetic underpinnings of human systemic lupus erythematosus (SLE).
• The genetic etiology of SLE involves a strong predisposition mediated by multiple gene variants.
• Many identified SLE-associated gene variants confer a substantial disease risk compared to other complex genetic disorders.

Approach:

• Reviewing current understanding of SLE genetic factors.
• Evaluating the potential for genetic information in personalized healthcare for SLE.
• Speculating on future applications of genetic insights in SLE management.

Key Points:

• The genetic architecture of SLE, characterized by multiple high-risk variants, supports the feasibility of personalized disease prediction.
• While current genetic knowledge is advancing, large-scale studies are essential to realize the full potential for predicting SLE onset and manifestations.
• Genetic insights hold promise for guiding individualized therapeutic strategies in SLE treatment.

Conclusions:

• The genetic basis of SLE presents a realistic opportunity for personalized prediction of disease onset and manifestation.
• Further extensive genetic research is crucial to translate this potential into clinical practice for SLE.
• Future applications may include using genetic information to tailor treatments for systemic lupus erythematosus.